We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Clinical trial reprograms myeloid cells to improve T cell function in melanoma patients resistant to treatment, suggesting new therapeutic strategies.
Clinicaltrials.gov ID, NCT04123470. First posted 2019-10-11.
No takes yet. Share an insight, caveat, or question.
Wiktorin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: